Frequency Therapeutics Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.00
Dividend & YieldN/A$ (N/A)
Beta 0.73
Market capitalization 74.05M
Operating cash flow -60.51M
ESG Scores unknown

Company description

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio11.79
Working Capital-0.69
Return On Equity-0.65
Debt To Equity0.11
Fixed Asset Ratio-0.47
Fixed Interest Cover-109.99

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 869k 50.41M -32.7M -16.36M
Total Cashflows From Investing Activities -436k -18.26M 10.4M -66.13M
Net Borrowings 5M 15M 15M
Total Cash From Financing Activities 41.71M 142.01M 56.69M 1.36M
Change To Operating Activities -50k -1.76M 2.46M -967k
Issuance Of Stock 73k 80.06M 41.69M 1.36M
Net Income -19.17M -18.75M -26.51M -84.69M
Change In Cash 24.25M 157.97M 21.9M -140.83M
Effect Of Exchange Rate
Total Cash From Operating Activities -17.02M 34.22M -45.19M -76.06M
Depreciation 654k 813k 1.15M 2.77M
Change To Account Receivables
Other Cashflows From Financing Activities 3.77M
Change To Netincome 671k 3.5M 10.42M 23.18M
Capital Expenditures -436k -1.06M -6.67M -2.91M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 36.02M 36.02M 36.02M 54.02M
Income Before Tax -19.17M -18.75M -26.48M -84.67M
Net Income -19.17M -18.75M -26.51M -84.69M
Selling General Administrative 7.43M 15.99M 28.51M 44.07M
Gross Profit -11.52M -4.68M 36.98M 14.07M
Ebit -18.94M -20.68M -27.55M -84.03M
Operating Income -18.94M -20.68M -27.55M -84.03M
Interest Expense -106k -764k -764k -764k
Income Tax Expense 35k 15k
Total Revenue 28.95M 36.98M 14.07M
Cost Of Revenue 11.52M 33.63M
Total Other Income ExpenseNet -224k 1.93M 1.07M -640k
Net Income From Continuing Ops -19.17M -18.75M -26.51M -84.69M
Net Income Applicable To Common Shares -19.17M -19.8M -26.51M -84.69M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 4.12M 55.86M 72.23M 54.53M
Total Stockholder Equity -48.28M 167.36M 192.49M 130.82M
Other Current Liabilities 161k 48.32M 14.07M
Total Assets 44.55M 223.22M 264.72M 185.36M
Common Stock 2k 31k 34k 35k
Other Current Assets 587k 1M 1.83M 1.04M
Retained Earnings -49.09M -68.89M -95.4M -180.09M
Treasury Stock 54k 27k -62k
Cash 42.19M 200.16M 220.34M 79.64M
Total Current Liabilities 3.77M 52.78M 26.63M 11.43M
Other Stockholder Equity 54k 27k -62k
Property, Plant, and Equipment 1.51M 1.76M 37.84M 36.87M
Total Current Assets 42.94M 221.35M 225.06M 134.75M
Net Tangible Assets -48.28M 167.36M 192.49M 130.82M
Net Receivables 161k 805k 340k 144k
Accounts Payable 1.86M 1.22M 5.51M 2.75M


Insider Transactions

Here are the insider transactions of stock shares related to Frequency Therapeutics Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
LEBEL CARLSale at price 1.52 per share.D2022-07-06Officer4.42k
MITRANO RICHARD J.Sale at price 1.54 per share.D2022-07-06Officer2.18k
LOOSE CHRISTOPHER RSale at price 1.53 per share.D2022-07-06Officer4.42k
ARNOLD WENDY SSale at price 1.52 per share.D2022-07-06Officer5.64k
MCCUBBIN QUENTINSale at price 1.52 per share.D2022-07-06Officer6.57k
LEBEL CARLD2022-07-05Officer15k
MITRANO RICHARD J.D2022-07-05Officer7.5k
LOOSE CHRISTOPHER RD2022-07-05Officer15k
ARNOLD WENDY SD2022-07-05Officer15k
MCCUBBIN QUENTIND2022-07-05Officer17.5k
LEBEL CARLSale at price 3.53 - 3.87 per share.D2022-02-22Officer2.04k
PFREUNDSCHUH PETER PSale at price 3.53 - 3.88 per share.D2022-02-22Chief Financial Officer2.95k
LOOSE CHRISTOPHER RSale at price 3.53 - 3.87 per share.D2022-02-22Officer2.04k
ARNOLD WENDY SSale at price 3.53 - 3.87 per share.D2022-02-22Officer2.54k
MCCUBBIN QUENTINSale at price 3.53 - 3.87 per share.D2022-02-22Officer3k
LEBEL CARLSale at price 4.19 - 4.43 per share.D2022-02-17Officer1.73k
PFREUNDSCHUH PETER PSale at price 4.20 - 4.43 per share.D2022-02-17Chief Financial Officer2.52k
LOOSE CHRISTOPHER RSale at price 4.19 - 4.43 per share.D2022-02-17Officer1.75k
ARNOLD WENDY SSale at price 4.19 - 4.43 per share.D2022-02-17Officer2.17k
MCCUBBIN QUENTINSale at price 4.20 - 4.43 per share.D2022-02-17Officer2.54k
LEBEL CARLSale at price 4.33 per share.D2022-02-15Officer844
PFREUNDSCHUH PETER PSale at price 4.33 per share.D2022-02-15Chief Financial Officer1.35k
LOOSE CHRISTOPHER RSale at price 4.33 per share.D2022-02-15Officer863
ARNOLD WENDY SSale at price 4.33 per share.D2022-02-15Officer1.17k
MCCUBBIN QUENTINSale at price 4.33 per share.D2022-02-15Officer1.26k
LEBEL CARLD2022-02-14Officer15k
PFREUNDSCHUH PETER PD2022-02-14Chief Financial Officer15k
LOOSE CHRISTOPHER RD2022-02-14Officer15k
ARNOLD WENDY SD2022-02-14Officer15k
MCCUBBIN QUENTIND2022-02-14Officer17.5k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2022-01-18Chief Executive Officer6.91k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-12-20Chief Executive Officer6.91k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-11-02Chief Executive Officer6.91k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-10-05Chief Executive Officer6.91k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-09-03Chief Executive Officer6.91k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-08-03Chief Executive Officer6.91k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-07-01Chief Executive Officer6.91k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-06-21Chief Executive Officer113.69k
MCCUBBIN QUENTINPurchase at price 8.85 per share.D2021-05-17Officer10k
MARCUS JOEL SConversion of Exercise of derivative security at price 3.37 per share.D2021-03-25Director37.12k
LUCCHINO DAVID L.Sale at price 47.84 - 52.11 per share.D2021-03-01Chief Executive Officer9.42k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-03-01Chief Executive Officer9.42k
LUCCHINO DAVID L.Sale at price 52.50 - 57.50 per share.D2021-02-08Chief Executive Officer16.55k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-02-08Chief Executive Officer16.55k
LUCCHINO DAVID L.Sale at price 47.50 - 50.00 per share.D2021-02-03Chief Executive Officer11.04k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-02-03Chief Executive Officer11.04k
LOOSE CHRISTOPHER RSale at price 45.02 - 47.19 per share.D2021-02-03Officer10k
LUCCHINO DAVID L.Sale at price 45.76 - 47.36 per share.D2021-02-02Chief Executive Officer5.52k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-02-02Chief Executive Officer5.52k
LUCCHINO DAVID L.Sale at price 41.29 - 44.58 per share.D2021-02-01Chief Executive Officer33.1k
LUCCHINO DAVID L.Conversion of Exercise of derivative security at price 0.61 per share.D2021-02-01Chief Executive Officer33.1k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Frequency Therapeutics Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Frequency Therapeutics Inc

Here is the result of two systematic investment strategies applied to Frequency Therapeutics Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Frequency Therapeutics Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Frequency Therapeutics Inc:

Frequency Therapeutics Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -49.18% on the backtest period.

Performance at glance

Performance

-49.18 %

Latent gain

-501.26 $

Invested capital

1019.18 $

Annualized return

-22.15 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Frequency Therapeutics Inc

This is the result of two momentum investment strategies applied to Frequency Therapeutics Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Frequency Therapeutics Inc

The following chart shows all the entries opened by the momentum investment system on Frequency Therapeutics Inc:

Frequency Therapeutics Inc momentum entries
  • The first momentum investment strategy would give -49.68% of return on Frequency Therapeutics Inc. That represents -1102.84$ of latent gain with 2219.8$ of employed capital.
  • The second momentum investment strategy would give -62.17% of return on Frequency Therapeutics Inc. That represents -933.05$ of latent gain with 1500.89$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-49.68 %

Latent gain

-1102.84 $

Invested capital

2219.8 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-62.17 %

Latent gain

-933.05 $

Invested capital

1500.89 $

Annualized return

-35.73 %

Momentum equity curve on Frequency Therapeutics Inc

The following chart shows the equity curve of the two momentum strategies applied to Frequency Therapeutics Inc:

Frequency Therapeutics Inc momentum equity

Note: the dividends potentially given by Frequency Therapeutics Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Frequency Therapeutics Inc

The following chart shows the employed capital evolution of the two momentum strategies on Frequency Therapeutics Inc since the beginning:

Frequency Therapeutics Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Frequency Therapeutics Inc

Buy the dip entry openings on Frequency Therapeutics Inc

Frequency Therapeutics Inc

The performance achieved by the robo-advisor on Frequency Therapeutics Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Frequency Therapeutics Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Frequency Therapeutics Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Frequency Therapeutics Inc

The following chart shows the result of the investment strategy applied to Frequency Therapeutics Inc:

Frequency Therapeutics Inc

Note: the dividends potentially given by Frequency Therapeutics Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Frequency Therapeutics Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Frequency Therapeutics Inc:

Frequency Therapeutics Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Frequency Therapeutics Inc

In this section, I will compare the three previous investment strategies applied to Frequency Therapeutics Inc.

Equity curve comparison on Frequency Therapeutics Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Frequency Therapeutics Inc investment strategy comparison

Employed capital comparison on Frequency Therapeutics Inc

Frequency Therapeutics Inc investment comparison

Performance comparison on Frequency Therapeutics Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -49.18% -501.26$ 1019.18$ -22.15%
Momentum 1 quarter -49.68% -1102.84$ 2219.8$ -25.09%
Momentum 2 quarters -62.17% -933.05$ 1500.89$ -35.73%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

-22.15 %

Momentum 1Q

-35.73 %

Momentum 2Q

-35.73 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Frequency Therapeutics Inc:

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

  • Guardant Health Inc

  • Note: The algorithm computes the probability of correlation between Frequency Therapeutics Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Frequency Therapeutics Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Frequency Therapeutics Inc
    Country United States
    City Lexington
    Address 75 Hayden Avenue
    Phone 781 315 4600
    Website www.frequencytx.com
    FullTime employees 72
    Industry Biotechnology
    Sector Healthcare
    Exchange XNAS
    Ticker FREQ
    Market www.nasdaq.com

    Frequency Therapeutics Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown